IL6 and neoplasm: In particular, during tumor initiation, the IL-6/STAT3 signal promotes the generation of pathogenic Th17 cells and MDSCs, suppressing antigen-presenting dendritic cells and antitumor cytotoxic CD8+ T cells and promoting regulatory T (Treg)-cell activity and tumor-associated macrophage phenotype switching from tumorigenic M1-type traits to immunosuppressive M2-type traits.